HB 2260 (see companion bill SB 174) – Kansas

Status: Inactive / Dead
Year Introduced: 2021
Link: http://www.kslegislature.org/li/b2021_22/measures/hb2260/

Prohibiting disparate treatment by pharmacy benefits managers of certain pharmacies and pharmaceutical services providers participating in the federal 340B drug pricing program.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found